127 related articles for article (PubMed ID: 38737661)
1. Examining prevalence and predictors of pulmonary hypertension in adults with idiopathic pulmonary fibrosis: a population-based analysis in the United States.
Desai R; Katukuri N; Kanagala SG; Ghadge N; James A; Tajdin B; Nalla A; Vutukuru SD; Kotharu DM; Kadiyala A; Vyas A; Prajjwal P; Ogbu I
J Med Life; 2024 Jan; 17(1):35-40. PubMed ID: 38737661
[TBL] [Abstract][Full Text] [Related]
2. Respiratory comorbidities and risk of mortality in hospitalized patients with idiopathic pulmonary fibrosis.
Oda K; Yatera K; Fujino Y; Kido T; Hanaka T; Sennari K; Fushimi K; Matsuda S; Mukae H
Respir Investig; 2018 Jan; 56(1):64-71. PubMed ID: 29325684
[TBL] [Abstract][Full Text] [Related]
3. Combined Pulmonary Fibrosis Emphysema: Role of Cigarette Smoking and Pulmonary Hypertension in a Rural Cohort.
Sangani R; Ghio A; Culp S; Patel Z; Sharma S
Int J Chron Obstruct Pulmon Dis; 2021; 16():1873-1885. PubMed ID: 34188464
[TBL] [Abstract][Full Text] [Related]
4. Characterizing idiopathic pulmonary fibrosis patients using US Medicare-advantage health plan claims data.
Mortimer K; Hartmann N; Chan C; Norman H; Wallace L; Enger C
BMC Pulm Med; 2019 Jan; 19(1):11. PubMed ID: 30630460
[TBL] [Abstract][Full Text] [Related]
5. Characterizing Health Outcomes in Idiopathic Pulmonary Fibrosis using US Health Claims Data.
Mortimer KM; Bartels DB; Hartmann N; Capapey J; Yang J; Gately R; Enger C
Respiration; 2020; 99(2):108-118. PubMed ID: 31982886
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Idiopathic Pulmonary Fibrosis Improve with Obesity: A Rural Appalachian Experience.
Sangani RG; Ghio AJ; Mujahid H; Patel Z; Catherman K; Wen S; Parker JE
South Med J; 2021 Jul; 114(7):424-431. PubMed ID: 34215896
[TBL] [Abstract][Full Text] [Related]
7. Comorbidities and risk of mortality among hospitalized patients with idiopathic pulmonary fibrosis in Spain from 2002 to 2014.
Pedraza-Serrano F; Jiménez-García R; López-de-Andrés A; Hernández-Barrera V; Esteban-Hernández J; Sánchez-Muñoz G; Puente-Maestu L; de-Miguel-Díez J
Respir Med; 2018 May; 138():137-143. PubMed ID: 29724386
[TBL] [Abstract][Full Text] [Related]
8. Hospital cost and length of stay in idiopathic pulmonary fibrosis.
Mooney JJ; Raimundo K; Chang E; Broder MS
J Med Econ; 2017 May; 20(5):518-524. PubMed ID: 28092235
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary hypertension in idiopathic pulmonary fibrosis: prevalence and clinical progress.
Castria D; Refini RM; Bargagli E; Mezzasalma F; Pierli C; Rottoli P
Int J Immunopathol Pharmacol; 2012; 25(3):681-9. PubMed ID: 23058018
[TBL] [Abstract][Full Text] [Related]
10. Mechanical ventilation in idiopathic pulmonary fibrosis: a nationwide analysis of ventilator use, outcomes, and resource burden.
Mooney JJ; Raimundo K; Chang E; Broder MS
BMC Pulm Med; 2017 May; 17(1):84. PubMed ID: 28532459
[TBL] [Abstract][Full Text] [Related]
11. Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis.
Kim KH; Maldonado F; Ryu JH; Eiken PW; Hartman TE; Bartholmai BJ; Decker PA; Yi ES
Respir Res; 2010 Apr; 11(1):37. PubMed ID: 20398288
[TBL] [Abstract][Full Text] [Related]
12. Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older.
Collard HR; Chen SY; Yeh WS; Li Q; Lee YC; Wang A; Raghu G
Ann Am Thorac Soc; 2015 Jul; 12(7):981-7. PubMed ID: 25923447
[TBL] [Abstract][Full Text] [Related]
13. How does comorbidity influence survival in idiopathic pulmonary fibrosis?
Hyldgaard C; Hilberg O; Bendstrup E
Respir Med; 2014 Apr; 108(4):647-53. PubMed ID: 24529739
[TBL] [Abstract][Full Text] [Related]
14. In-hospital mortality trends among patients with idiopathic pulmonary fibrosis in the United States between 2013-2017: a comparison of academic and non-academic programs.
Alqalyoobi S; Fernández Pérez ER; Oldham JM
BMC Pulm Med; 2020 Nov; 20(1):289. PubMed ID: 33160338
[TBL] [Abstract][Full Text] [Related]
15. Utility of Endoscopy in Hospitalized Patients with Gastrointestinal Hemorrhage and Pulmonary Hypertension.
Singh A; Siddiqui MT; Al-Yaman W; Garg R; Jang S; Chahal P; Vargo J
Dig Dis Sci; 2021 Dec; 66(12):4159-4168. PubMed ID: 33428039
[TBL] [Abstract][Full Text] [Related]
16. Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study.
Ozaltin B; Chapman R; Arfeen MQU; Fitzpatick N; Hemingway H; Direk K; Jacob J
Respir Res; 2024 Jun; 25(1):249. PubMed ID: 38898447
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of pulmonary hypertension in patients with idiopathic pulmonary fibrosis: correlation with physiological parameters.
Papakosta D; Pitsiou G; Daniil Z; Dimadi M; Stagaki E; Rapti A; Antoniou K; Tzouvelekis A; Kontakiotis T; Tryfon S; Polychronopoulos V; Bouros D
Lung; 2011 Oct; 189(5):391-9. PubMed ID: 21660584
[TBL] [Abstract][Full Text] [Related]
18. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review.
Raghu G; Amatto VC; Behr J; Stowasser S
Eur Respir J; 2015 Oct; 46(4):1113-30. PubMed ID: 26424523
[TBL] [Abstract][Full Text] [Related]
19. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
[TBL] [Abstract][Full Text] [Related]
20. In-Hospital Mortality in Patients with Idiopathic Pulmonary Fibrosis: A US Cohort Study.
Durheim MT; Judy J; Bender S; Baumer D; Lucas J; Robinson SB; Mohamedaly O; Shah BR; Leonard T; Conoscenti CS; Palmer SM
Lung; 2019 Dec; 197(6):699-707. PubMed ID: 31541276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
